Clinical Research Directory
Browse clinical research sites, groups, and studies.
Promoting HIV Risk Reduction Among People Who Inject Drugs: A Stepped Care Approach Using Contingency Management With PrEP Adherence and Support Services
Sponsor: Yale University
Summary
The proposed study will be a 24-week intervention with a 12-month follow-up period to evaluate the impact of contingency management with stepped care to pre-exposure prophylaxis (PrEP) adherence and support services (CoMPASS) to promote HIV prevention among individuals with opioid use disorder who have injected drugs in their lifetime. In parallel, the investigators will conduct an implementation focused process evaluation to inform real-world implementation of CoMPASS. .
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
526
Start Date
2021-10-04
Completion Date
2026-06-30
Last Updated
2025-06-13
Healthy Volunteers
No
Interventions
Contingency Management with stepped care to PrEP adherence and support services (CoMPASS)
Participants will receive contingency management sessions (n=9). Participants who do not demonstrate PrEP adherence by week 12 will be "stepped up" to receive PrEP adherence and support services (n=5).
Locations (6)
Recovery Network of Programs, Inc
Bridgeport, Connecticut, United States
Liberations Program, Inc
Bridgeport, Connecticut, United States
Apex Community Care. Inc.
Danbury, Connecticut, United States
Greater Hartford Harm Reduction Coalition- SWAN
New Haven, Connecticut, United States
APT
New Haven, Connecticut, United States
Stanley Street Treatment and Resource Center
Fall River, Massachusetts, United States